2024, 19 November
Evaluating the Potential of Synthetic Patient Data...
Authors: M. Tornqvist1, L. Dry1, G. Pinon1, A. Movschin11Quinten Health, Paris, France Date: 19 November 2024 Code : MSR138 CONFERENCE/VALUE IN...
2024, 18 November
Use of Therapeutic Area-Specific Real-World Databa...
Authors: S. Levy1, L. Van Sante2, F. Magnard2, A. Fregeac3, MO. Gauci3 1Quinten Health, Paris, France, 2Quinten Health, Paris, 75, France, 3Nice...
2024, 04 January
Enhancing Patient-Centered Decision-Making: Quinte...
In efforts to push for the use of registry data to support patient-centered decision-making in regulatory and health technology assessment (HTA) pr...
2023, 26 October
Heading to ISPOR 2023, a deepdive in health econom...
Quinten Health joins ISPOR Europe 2023, the leading European conference for health economics and outcomes research (HEOR) in Copenhagen.We're...
2023, 16 May
Quinten Health receives the Top 5% Poster...
Quinten Health is proud to announce that it has received the "Top 5% Poster" award at the 2023 ISPOR conference ! This distinction was awarded to...
2023, 26 April
ISPOR Annual 2023
Quinten Health will be at ISPOR Annual 2023 in Boston!On May 7-10, Quinten Health will be at the at ISPOR 2023 in Boston ! We will present 3...
2022, 31 October
Our team will be at ISPOR Europe 2022
Quinten Health will be at ISPOR Europe 2022 in Vienna.Billy Amzal (CEO) will be at ISPOR Europe 2022 from Nov. 6th to Nov. 9th 2022 in Vienna,...
2018, 10 November
Compare renal function preservation outcome of SGL...
Authors: F.L. ZHOU, H. WATADA, Y. TAJIMA, M. Berthelot, D. Kang, C. Esnault, Y. SHUTO, H. MAEGAWA, D. KOYA Date: 10 November 2018...